Tissue Doppler Imaging (TDI) is an emergingnon-invasive ultrasound technique that makes it possible to measure velocities at any point of the ventricular wall during the cardiac cycle. Over the last ten years, TDI has been proposed as a feasible and useful imaging tool that provides information on regional wall motion dynamics.
Using the different shaped tips of ARC 350L and TissueSeal or Ligator instruments, made by Bowa, surgeons can permanently seal large veins, arteries or bunched tissue. All of these special tools gained a red dot award for ergonomics and practicality.
To help improve transfusion safety, in accordance with EU Directive 2002/98/EC, the Dutch National Haemovigilance Office, TRIP, receives and analyses reports of transfusion reactions and promotes haemovigilance.
A new testing approach has effectively identified patients at the highest risk of cancer relapse after bladder cancer surgery, according to a study published in the February issue of The Lancet Oncology http://oncology.thelancet.com. Vol 8 Feb 2007 91.
According to a study published in the December issue of the Journal of the National Cancer Institute the widespread concerns of cell phone users about an increased cancer risk are causeless. Cell phone antennas emit electromagnetic fields that can penetrate into the human brain, and scientists have wondered if this might cause tumors in the head or neck.
At the RSNA 2006 Siemens Medical Solutions announced it has received 510(k) approval from the U.S. Food and Drug Administration (FDA) for the first of many syngo® Dual Energy applications for the SOMATOM® Definition - the dual source computed tomography (DSCT) system.
USA - The Food and Drug Administration (FDA) recently cleared the incorporation of Hip Structure Analysis (HSA) software in Hologic dual-energy X-ray (DXA) bone densitometers.
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Although X-ray mammography can detect small cancers before they have spread. However, because abnormalities can only be identified non-specifically, percutaneous or surgical breast biopsy must follow - but less than 20% of women recalled for biopsies have cancer.
Dry Cut, a new cutting mode produced specifically for transurethral resection of the prostate (TUR-P), has been launched by Erbe Elektromedizin, of Tubingen, Germany. This, with High Cut and Auto Cut, means that Erbes VIO System now offers the entire range of cutting qualities needed for TUR-P, TUR-B and TUV-P procedures, the firm reports.